Arcus Biosciences, Inc. - stock earnings
RCUS Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -81.0 million USD | 31.0 million USD |
2023Q3 | -71.0 million USD | 32.0 million USD |
2023Q2 | -75.0 million USD | 29.0 million USD |
2023Q1 | -80.0 million USD | 25.0 million USD |
2022Q4 | -67.0 million USD | 345000 USD |
2022Q3 | -60.4 million USD | 33.6 million USD |
2022Q2 | -64.3 million USD | 26.8 million USD |
2022Q1 | -68.0 million USD | 18.0 million USD |
2021Q4 | 279.4 million USD | 354.5 million USD |
2021Q3 | -78.0 million USD | 9.5 million USD |
2021Q2 | -76.0 million USD | 9.5 million USD |
2021Q1 | -72.6 million USD | 9.5 million USD |
2020Q4 | -51.9 million USD | 9.5 million USD |
2020Q3 | 1.8 million USD | 64.5 million USD |
2020Q2 | -45.1 million USD | 1.8 million USD |
2020Q1 | -27.8 million USD | 1.8 million USD |
2019Q4 | -16.6 million USD | 9.8 million USD |
2019Q3 | -22.4 million USD | 1.8 million USD |
2019Q2 | -28.1 million USD | 1.8 million USD |
2019Q1 | -17.7 million USD | 1.8 million USD |
2018Q4 | -12.3 million USD | 1.6 million USD |
2018Q3 | -10.8 million USD | 4.3 million USD |
2018Q2 | -13.5 million USD | 1.3 million USD |
2018Q1 | -13.0 million USD | 1.3 million USD |
2017Q4 | -13.2 million USD | 1.3 million USD |
2017Q3 | -23.1 million USD | 163000 USD |
2017Q2 | -9.6 million USD | ? USD |
2017Q1 | -7.2 million USD | ? USD |
2016Q4 | -18.0 million USD | ? USD |
RCUS Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -307.0 million USD | 117.0 million USD |
2022 | -267.0 million USD | 112.0 million USD |
2021 | 53.0 million USD | 382.9 million USD |
2020 | -116.7 million USD | 77.5 million USD |
2019 | -75.9 million USD | 15.0 million USD |
2018 | -49.6 million USD | 8.4 million USD |
2017 | -53.1 million USD | 1.4 million USD |
2016 | -18.0 million USD | ? USD |
RCUS
Price: $15.23
52 week price:
Earnings Per Share: -4.15 USD
P/E Ratio: -3.83
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 965900
Market Capitalization: 1.6 billion